Chatham Capital Group, Inc. Inogen Inc Transaction History

Chatham Capital Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$28.1 - $35.25 $579,028 - $726,361	-20,606 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$29.66 - $44.0 $52,349 - $77,660	-1,765 Reduced 7.89%	20,606 $701,000
Q3 2021 Oct 13, 2021	SELL	$43.09 - $82.26 $10,255 - $19,577	-238 Reduced 1.05%	22,371 $969,000
Q2 2021 Jul 28, 2021	BUY	$52.03 - $68.77 $156 - $206	3 Added 0.01%	22,609 $1.47 Million
Q1 2021 Apr 29, 2021	BUY	$43.96 - $55.99 $45,015 - $57,333	1,024 Added 4.74%	22,606 $1.19 Million

Q3 2020 Oct 22, 2020	BUY	$27.01 - $37.31 $1,539 - $2,126	57 Added 0.26%	21,582 $626,000
Q2 2020 Jul 20, 2020	BUY	$32.85 - $53.77 $3,777 - $6,183	115 Added 0.54%	21,525 $765,000
Q1 2020 May 01, 2020	BUY	$32.63 - $67.59 $698,608 - $1.45 Million	21,410 New	21,410 $1.11 Million

138

21.8M

252K

183K

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $189M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

Get notified when there are updates to the investment portfolio of Chatham Capital Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Chatham Capital Group, Inc. with notifications on news.